Meningitis B Outbreak Expands to Fourth Kent School, Prompting Emergency Vaccine Drive
A fourth school in Kent has reported a suspected case of meningitis, as health officials confirm the outbreak is spreading rapidly across the region. Pharmacists have noted a significant surge in demand for the MenB vaccine, indicating heightened public concern over the escalating situation.
Health Secretary Declares Outbreak 'Unprecedented'
Health Secretary Wes Streeting has described the Canterbury outbreak as 'unprecedented' and a 'rapidly developing situation'. In response, the UK Health Security Agency (UKHSA) has launched a targeted vaccination programme aimed at students residing in University of Kent halls of residence. Additionally, 700 doses of antibiotics have been distributed to contain the spread of the disease.
Case Numbers Rise with Hospitalisations Required
The total number of confirmed meningitis cases has now reached 15, marking an increase of two from Monday. All affected individuals have required hospitalisation, underscoring the severity of the outbreak. Experts have characterised the situation as 'unusual', with two fatalities reported: an 18-year-old pupil and an unnamed 21-year-old university student. Laboratory tests have confirmed Meningitis B in some of these cases.
Public Health Response Intensifies
The UKHSA's emergency measures include:
- Targeted vaccination for at-risk student populations.
- Distribution of antibiotics to prevent further infections.
- Enhanced surveillance and monitoring in affected schools and communities.
Health authorities are urging parents and students to remain vigilant for symptoms such as severe headaches, fever, and neck stiffness, and to seek immediate medical attention if any signs appear.
